Advances in the understanding of cytokine signal transduction: The role of Jaks and STATs in immunoregulation and the pathogenesis of immunodeficiency

Journal of Clinical Immunology

Volumn 17, Issue 6, 1997, Pages 431-447

  O'Shea, John J ^a   Notarangelo, Luigi D ^b   Johnston, James A ^c   Candotti, Fabio ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF BRESCIA   (Italy)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cytokines; Immunodeficiency; Immunoregulation; Jaks; Signal transruction; STATs

Indexed keywords

CYTOKINE; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH HORMONE; MONOPHENOL MONOOXYGENASE; PROLACTIN; THROMBOPOIETIN;

ARTICLE; AUTOSOMAL INHERITANCE; DIMERIZATION; GENETIC TRANSCRIPTION; HEMATOPOIESIS; HOST RESISTANCE; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOREGULATION; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION INITIATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CYTOKINES; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INTERFERON TYPE II; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 0031440585     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027388508570     Document Type: Article

References (215)

1. Davies DR, Wlodawer A: Cytokines and their receptor complexes. FASEB J 9:50-56, 1995
2. Bazan JF: Haemopoietic receptors and helical cytokines. Immunol Today 11:350-354, 1990
3. Cosman D: The hematopoietin receptor superfamily. Cytokine 5:95-106, 1993
4. Taga T, Kishimoto T: Signaling mechanisms through cytokine receptors that share signal transducing receptor components. Curr Opin Immunol 7:17-23, 1995
5. Leonard WJ: The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling. Annu Rev Med 47:229-239, 1996
6. Cosman D, Kumaki S, Ahdieh M, Eisenman J, Grabstein KH, Paxton R, DuBose R, Friend D, Park LS, Anderson D, et al.: Interleukin 15 and its receptor. Ciba Found Symp 195:221-229; 229-233, 1995
7. Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D: Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 13:2822-2830, 1994
8. Giri JG, Kumaki S, Ahdieh M, Friend DJ, Loomis A, Shanebeck K, DuBose R, Cosman D, Park LS, Anderson DM: Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J 14:3654-3663, 1995
9. Kumaki S, Armitage R, Ahdieh M, Park L, Cosman D: Interleukin-15 up-regulates interleukin-2 receptor alpha chain but down-regulates its own high-affinity binding sites on human T and B cells. Eur J Immunol 26:1235-1239, 1996
10. Tagaya Y, Bamford RN, DeFilippis AP, Waldmann TA: IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 4:329-336, 1996
11. Tagaya Y, Burton JD, Miyamoto Y, Waldmann TA: Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. EMBO J 15:4928-4939, 1996
12. Zurawski SM, Vega FJ, Huyghe B, Zurawski G: Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J 12: 2663-2670, 1993
13. Callard RE, Matthews DJ, Hibbert L: IL-4 and IL-13 receptors: Are they one and the same? Immunol Today 17:108-110, 1996
14. Hilton DJ, Zhang JG, Metcalf D, Alexander WS, Nicola NA, Willson TA: Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci USA 93:497-501, 1996
15. Caput D, Laurent P, Kaghad M, Lelias JM, Lefort S, Vita N, Ferrara P: Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J Biol Chem 271:16921-16926, 1996
16. Aman MJ, Tayebi N, Obiri NI, Puri RK, Modi WS, Leonard WJ: cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J Biol Chem 271:29265-29270, 1996
17. Bach EA, Aguet M, Schreiber RD: The IFN-gamma receptor: A paradigm for cytokine receptor signaling. Annu Rev Immunol 15:563-593, 1997
18. Chua AO, Wilkinson VL, Presky DH, Gubler U: Cloning and characterization of a mouse IL-12 receptor-beta component. J Immunol 155:4286-4294, 1995
19. Rogge L, Barberis-Maino L, Biffi M, Passini N, Presky DH, Gubler U, Sinigaglia F: Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 185:825-831, 1997
20. Szabo SJ, Dighe AS, Gubler U, Murphy KM: Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med 185:817-824, 1997
21. Paul WE, Seder RA: Lymphocyte responses and cytokines. Cell 76:241-251, 1994
22. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 383:787-793, 1996
23. Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu CY, Ferrante J, Stewart C, Sarmiento U, Faherty DA, Gately MK: IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 4:471-481, 1996
24. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA: Multiple defects of immune cell function in mice with disrupted interferon-gamma genes, Science 259:1739-1742, 1993
25. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel RM, Aguet M: Immune response in mice that lack the interferon-gamma receptor. Science 259:1742-1745, 1993
26. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, Levin M: A mutation in the interferongamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 335:1941-1949, 1996
27. Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile JF, Newport M, Levin M, Blanche S, Seboun E, Fischer A, Casanova JL: Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med 335:1956-1961, 1996
28. Kuhn R, Rajewsky K, Muller W: Generation and analysis of interleukin-4 deficient mice. Science 254:707-710, 1991
29. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Kohler G: Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245-248, 1993
30. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W: Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263-274, 1993
31. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R: Lymphopenia in interleukin (IL)-7 gene-deleted mice identities IL-7 as a nonredundant cytokine. J Exp Med 181:1519-1526, 1995
32. Maraskovsky E, Teepe M, Morrissey PJ, Braddy S, Miller RE, Lynch DH, Peschon JJ: Impaired survival and proliferation in IL-7 receptor-deficient peripheral T cells. J Immunol 157:5315-5323, 1996
33. He YW, Malek TR: Interleukin-7 receptor alpha is essential for the development of gamma delta + T cells, but not natural killer cells. J Exp Med 184:289-293, 1996
34. Kundig TM, Schorle H, Bachmann MF, Hengartner H, Zinkernagel RM, Horak I: Immune responses in interleukin-2-deficient mice. Science 262:1059-1061, 1993
35. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I: Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253-261, 1993
36. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW: Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521-530, 1995
37. Suzuki H, Kundig TM, Furlonger C, Wakeham A, Timms E, Matsuyama T, Schmits R, Simard JJ, Ohashi PS, Griesser H, et al.: Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268:1472-1476, 1995
38. Sharfe N, Dadi HK, Shahar M, Roifman CM: Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor. Proc Natl Acad Sci USA 94:3168-3171, 1997
39. Wilks AF, Harpur AG, Kurban RR, Ralph SJ, Zurcher G, Ziemiecki A: Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase. Mol Cell Biol 11:2057-2065, 1991
40. Harpur AG, Andres AC, Ziemiecki A, Aston RR, Wilks AF: JAK2, a third member of the JAK family of protein tyrosine kinases. Oncogene 7:1347-1353, 1992
41. Silvennoinen O, Witthuhn BA, Quelle FW, Cleveland JL, Yi T, Ihle JN: Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proc Natl Acad Sci USA 90:8429-8433, 1993
42. Firmbach-Kraft I, Byers M, Shows T, Dalla-Favera R, Krolewski JJ: tyk2, prototype of a novel class of non-receptor tyrosine kinase genes, Oncogene 5:1329-1336, 1990
43. Velazquez L, Fellous M, Stark GR, Pellegrini S: A protein tyrosine kinase in the Interferon alpha/beta signaling pathway. Cell 70:313-322, 1992
44. Kawamura M, McVicar DW, Johnston JA, Blake TB, Chen YQ, Lal BK, Lloyd AR, Kelvin DJ, Staples JE, Ortaldo JR, O'Shea JJ: Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes. Proc Natl Acad Sci USA 91:6374-6378, 1994
45. Witthuhn BA, Silvennoinen O, Miura O, Lai KS, Cwik C, Liu ET, Ihle JN: Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 370:153-157, 1994
46. Gurniak CB, Berg LJ: Murine JAK3 is preferentially expressed in hematopoietic tissues and lymphocyte precursor cells. Blood 87:3151-3160, 1996
47. Takahashi T, Shirasawa T: Molecular cloning of rat JAK3, a novel member of the JAK family of protein tyrosine kinases. FEBS Lett 342:124-128, 1994
48. Rane SG, Reddy EP: JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells. Oncogene 9:2415-2423, 1994
49. Musso T, Johnston JA, Linnekin D, Varesio L, Rowe TK, O'Shea JJ, McVicar DW: Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7. J Exp Med 181:1425-1431, 1995
50. Tortolani PJ, Lal BK, Riva A, Johnston JA, Chen YQ, Reaman GH, Beckwith M, Longo D, Ortaldo JR, Bhatia K, Magrath I, Kehrl J. O'Shea JJ: Regulation of JAK3 expression and activation in human B cells and B cell malignancies. J Immunol 155:5220-5226, 1995
51. Verbsky JW, Bach EA, Fang YF, Yang L, Randolph DA, Fields LE: Expression of Janus kinase 3 in human endothelial and other non-lymphoid and non-myeloid cells. J Biol Chem 271:13976-13980, 1996
52. Lai KS, Jin Y, Graham DK, Witthuhn BA, Ihle JN, Liu ET: A kinase-deficient splice variant of the human JAK3 is expressed in hematopoietic and epithelial cancer cells. J Biol Chem 270: 25028-25036, 1995
53. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Silvennoinen O: Signaling through the hematopoietic cytokine receptors. Annu Rev Immunol 13:369-398, 1995
54. Riedy MC, Dutra AS, Blake TB, Modi W, Lal BK, Davis J, Bosse A, O'Shea JJ, Johnston JA: Genomic sequence, organization, and chromosomal localization of human JAK3. Genomics 37:57-61, 1996
55. Kumar A, Toscani A, Rane S, Reddy EP: Structural organization and chromosomal mapping of JAK3 locus. Oncogene 13:2009-2014, 1996
56. Zhao Y, Wagner F, Frank SJ, Kraft AS: The amino-terminal portion of the JAK2 protein kinase is necessary for binding and phosphorylation of the granulocyte-macrophage colonystimulating factor receptor beta c chain. J Biol Chem 270:13814-13818, 1995
57. Frank SJ, Yi W, Zhao Y, Goldsmith JF, Gilliland G, Jiang J, Sakai I, Kraft AS: Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor. J Biol Chem 270:14776-14785, 1995
58. Chen M, Cheng A, Chen Y-Q, Hymel A, Hanson EP, Kimmel L, Minami Y, Taniguchi T, Changelian PS, O'Shea JJ: The amino terminus of JAK3 is necessary and sufficient for binding to the common γ chain and confers the ability to transmit interleukin 2-mediated signals. Proc Natl Acad Sci USA 94:6910-6915, 1997
59. Kohlhuber F, Rogers NC, Watling D, Feng J, Guschin D, Briscoe J, Witthuhn BA, Kotenko SV, Pestka S, Stark GR, Ihle JN, Kerr IM: A JAK1/JAK2 chimera can sustain alpha and gamma Interferon responses. Mol Cell Biol 17:695-706, 1997
60. Watling D, Guschin D, Muller M, Silvennoinen O, Witthuhn BA, Quelle FW, Rogers NC, Schindler C, Stark GR, Ihle JN, et al.: Complementation by the protein tyrosine kinase JAK2 of a mutant cell line detective in the interferon-gamma signal transduction pathway. Nature 366:166-170, 1993
61. Muller M, Briscoe J, Laxton C, Guschin D, Ziemiecki A, Silvennoinen O, Harpur AG, Barbieri G, Witthuhn BA, Schindler C, et al.: The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction. Nature 366:129-135, 1993
62. Darnell JEJ, Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421, 1994
63. Schindler C, Darnell JEJ: Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 64: 621-651, 1995
64. Ihle JN: Cytokine receptor signalling. Nature 377:591-594, 1995
65. Russell SM, Tayebi N, Nakajima H, Riedy MC, Roberts JL, Aman MJ, Migone TS, Noguchi M, Markert ML, Buckley RH, et al.: Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270:797-800, 1995
66. Candotti F, Oakes SA, Johnston JA, Notarangelo LD, O'Shea JJ, Blaese RM: In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction. J Exp Med 183:2687-2692, 1996
67. Oakes SA, Candotti F, Johnston JA, Chen YQ, Ryan JJ, Taylor N, Liu X, Hennighausen L, Notarangelo LD, Paul WE, Blaese RM, O'Shea JJ: Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways. Immunity 5:605-615, 1996
68. Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, Ihle JN, Carter-Su C: Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74: 237-244, 1993
69. Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O. Ihle JN: JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin, Cell 74:227-236, 1993
70. Stahl N, Boulton TG, Farruggella T, Ip NY, Davis S, Witthuhn BA, Quelle FW, Silvennoinen O, Barbieri G, Pellegrini S, et al.: Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science 263:92-95, 1994
71. Quelle FW, Sato N, Witthuhn BA, Inhorn RC, Eder M, Miyajima A, Griffin JD, Ihle JN: JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol Cell Biol 14:4335-4341, 1994
72. Johnston JA, Kawamura M, Kirken RA, Chen YQ, Blake TB, Shibuya K, Ortaldo JR, McVicar DW, O'Shea JJ: Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 370:151-153, 1994
73. Russell SM, Johnston JA, Noguchi M, Kawamura M, Bacon CM, Friedmann M, Berg M, McVicar DW, Witthuhn BA, Silvennoinen O, et al.: Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. Science 266:1042-1045, 1994
74. Miyazaki T, Kawahara A, Fujii H, Nakagawa Y, Minami Y, Liu ZJ, Oishi I, Silvennoinen O, Witthuhn BA, Ihle JN, et al.: Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 266:1045-1047, 1994
75. Boussiotis VA, Barber DL, Nakarai T, Freeman GJ, Gribben JG, Bernstein GM, D'Andrea AD, Ritz J, Nadler LM: Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor. Science 266:1039-1042, 1994
76. Colamonici O, Yan H, Domanski P, Handa R, Smalley D, Mullersman J, Witte M, Krishnan K, Krolewski J: Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase. Mol Cell Biol 14:8133-8142, 1994
77. Novick D, Cohen B, Rubinstein M: The human interferon alpha/beta receptor: Characterization and molecular cloning. Cell 77:391-400, 1994
78. Abramovich C, Shulman LM, Ratovitski E, Harroch S, Tovey M, Eid P, Revel M: Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta. EMBO J 13:5871-5877, 1994
79. Sakatsume M, Igarashi K, Winestock KD, Garotta G, Larner AC, Finbloom DS: The Jak kinases differentially associate with the alpha and beta (accessory factor) chains of the interferon gamma receptor to form a functional receptor unit capable of activating STAT transcription factors. J Biol Chem 270:17528-17534, 1995
80. Kotenko SV, Izotova LS, Pollack BP, Mariano TM, Donnelly RJ, Muthukumaran G, Cook JR, Garotta G, Silvennoinen O, Ihle JN, et al.: Interaction between the components of the interferon gamma receptor complex. J Biol Chem 270:20915-20921, 1995
81. Bach EA, Tanner JW, Marsters S, Ashkenazi A, Aguet M, Shaw AS, Schreiber RD: Ligand-induced assembly and activation of the gamma interferon receptor in intact cells. Mol Cell Biol 16:3214-3221, 1996
82. de Vos AM, Ultsch M, Kossiakoff AA: Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 255:306-312, 1992
83. Walter MR, Windsor WT, Nagabhushan TL, Lundell DJ, Lunn CA, Zauodny PJ, Narula SK: Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor [see comments]. Nature 376:230-235, 1995
84. Longmore GD, Lodish HF: An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: A cytokine receptor superfamily oncogene. Cell 67:1089-1102, 1991
85. Nakamura Y, Russell SM, Mess SA, Friedmann M, Erdos M, Francois C, Jacques Y, Adelstein S, Leonard WJ: Heterodimimerization of the IL-2 receptor beta-and gamma-chain cytoplasmic domains is required for signalling. Nature 369:330-333, 1994
86. Nelson BH, Lord JD, Greenberg PD: Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation. Nature 369:333-336, 1994
87. Guschin D, Rogers N, Briscoe J, Witthuhn B, Watling D, Horn F, Pellegrini S, Yasukawa K, Heinrich P, Stark GR, et al.: A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. EMBO J 14:1421-1429, 1995
88. Pawson T: Protein modules and signalling networks. Nature 373:573-580, 1995
89. Fu XY: A transcription factor with SH2 and SH3 domains is directly activated by an Interferon alpha-induced cytoplasmic protein tyrosine kinase(s). Cell 70:323-335, 1992
90. Fu XY, Schindler C, Improta T, Aebersold R, Darnell JEJ: The proteins of ISGF-3, the interferon alpha-induced transcriptional activator, define a gene family involved in signal transduction. Proc Natl Acad Sci USA 89:7840-7843, 1992
91. Zhong Z, Wen Z, Darnell JEJ: Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264:95-98, 1994
92. Akira S, Nishio Y, Inoue M, Wang XJ, Wei S, Matsusaka T, Yoshida K, Sudo T, Naruto M, Kishimoto T: Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 77:63-71, 1994
93. Zhong Z, Wen Z, Darnell JEJ: Stat3 and Stat4: Members of the family of signal transducers and activators of transcription. Proc Natl Acad Sci USA 91:4806-4810, 1994
94. Yamamoto K, Quelle FW, Thierfelder WE, Kreider BL, Gilbert DJ, Jenkins NA, Copeland NG, Silvennoinen O, Ihle JN: Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation. Mol Cell Biol 14:4342-4349, 1994
95. Wakao H, Gouilleux F, Groner B: Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response [published erratum appears in EMBO J 14(4):854-855, 1995]. EMBO J 13:2182-2191, 1994
96. Hou J, Schindler U, Henzel WJ, Wong SC, McKnight SL: Identification and purification of human Stat proteins activated in response to interleukin-2. Immunity 2:321-329, 1995
97. Mui AL, Wakao H. O'Farrell AM, Harada N, Miyajima A: Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs. EMBO J 14:1166-1175, 1995
98. Azam M, Erdjument-Bromage H, Kreider BL, Xia M, Quelle F, Basu R, Saris C, Tempst P, Ihle JN, Schindler C: Interleukin-3 signals through multiple isoforms of Stat5. EMBO J 14:1402-1411, 1995
99. Liu X, Robinson GW, Gouilleux F, Groner B, Hennighausen L: Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc Natl Acad Sci USA 92:8831-8835, 1995
100. Lin JX, Mietz J, Modi WS, John S, Leonard WJ: Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells. J Biol Chem 271:10738-10744, 1996
101. Hou J, Schindler U, Henzel WJ, Ho TC, Brasseur M, McKnight SL: An interleukin-4-induced transcription factor: IL-4 Stat. Science 265:1701-1706, 1994
102. Copeland NG, Gilbert DJ, Schindler C, Zhong Z, Wen Z, Darnell JEJ, Mui AL, Miyajima A, Quelle FW, Ihle JN, et al.: Distribution of the mammalian Stat gene family in mouse chromosomes. Genomics 29:225-228, 1995
103. Greenlund AC, Morales MO, Viviano BL, Yan H, Krolewski J, Schreiber RD: Stat recruitment by tyrosine-phosphorylated cytokine receptors: An ordered reversible affinity-driven process. Immunity 2:677-687, 1995
104. Schindler U, Wu P, Rothe M, Brasseur M, McKnight SL: Components of a Stat recognition code: evidence for two layers of molecular selectivity. Immunity 2:689-697, 1995
105. Lin JX, Migone TS, Tsang M, Friedmann M, Weatherbee JA, Zhou L, Yamauchi A, Bloom ET, Mietz J, John S, et al.: The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2:331-339, 1995
106. Bacon CM, Petricoin EF, Ortaldo JR, Rees RC, Larner AC, Johnston JA, O'Shea JJ: Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc Natl Acad Sci USA 92:7307-7311, 1995
107. Jacobson NG, Szabo SJ, Weber-Nordt RM, Zhong Z, Schreiber RD, Darnell JEJ, Murphy KM: Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J Exp Med 181:1755-1762, 1995
108. Cho SS, Bacon CM, Sudarshan C, Rees RC, Finbloom D, Pine R, O'Shea JJ: Activation of STAT4 by IL-12 and IFN-alpha: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. J Immunol 157:4781-4789, 1996
109. Johnston JA, Bacon CM, Riedy MC, O'Shea JJ: Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency. J Leukoc Biol 60:441-452, 1996
110. Leonard WJ: Stats and cytokine specificity. Nature Med 2:968-969, 1996
111. Ihle JN: STATs: signal transducers and activators of transcription. Cell 84:331-334, 1996
112. Yamamoto K, Miura O, Hirosawa S, Miyasaka N: The binding sequence of STAT4. Biochem Biophys Res Commun 233:126-132, 1997
113. Wen Z, Zhong Z, Darnell JEJ: Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241-250, 1995
114. Boulton TG, Zhong Z, Wen Z, Darnell JEJ, Stahl N, Yancopoulos GD: STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase. Proc Natl Acad Sci USA 92:6915-6919, 1995
115. Zhang X, Blenis J, Li HC, Schindler C, Chen-Kiang S: Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 267:1990-1994, 1995
116. David M, Petricoin ER, Benjamin C, Pine R, Weber MJ, Larner AC: Requirement for MAP kinase (ERK2) activity in interferon alpha-and interferon beta-stimulated gene expression through STAT proteins [see comments]. Science 269:1721-1723, 1995
117. Moriggl R, Gouilleux-Gruart V, Jahne R, Berchtold S, Gartmann C, Liu X, Hennighausen L, Sotiropoulos A, Groner B, Gouilleux F: Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol Cell Biol 16:5691-5700, 1996
118. Moriggl R, Berchtold S, Friedrich K, Standke GJR, Kammer W, Heim M, Wissler M, Stocklin E, Gouilleux F, Groner B: Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells. Mol Cell Biol 17:3663-3678, 1997
119. Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D'Andrea A, Livingston DM: Cooperation of Stat2 and p300/ CBP in signalling induced by interferon-alpha. Nature 383:344-347, 1996
120. Zhang JJ, Vinkemeier U, Gu W, Chakravarti D, Horvath CM, Darnell JEJ: Two contact regions between Stat1 and CBP/p300 in Interferon gamma signaling. Proc Natl Acad Sci USA 93:15092-15096, 1996
121. Horvai AE, Xu L, Korzus E, Brard G, Kalafus D, Mullen TM, Rose DW, Rosenfeld MG, Glass CK: Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc Natl Acad Sci USA 94:1074-1079, 1997
122. Xu X, Sun YL, Hoey T: Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science 273:794-797, 1996
123. Horvath CM, Darnell JE: The state of STATs: Recent developments in the study of signal transduction to the nucleus. Curr Opin Cell Biol 9:233-239, 1997
124. Horvath CM, Stark GR, Kerr IM, Darnell JEJ: Interactions between STAT and non-STAT proteins in the interferon-stimulated gene factor 3 transcription complex. Mol Cell Biol 16:6957-6964, 1996
125. Look DC, Pelletier MR, Tidwell RM, Roswit WT, Holtzman MJ: Stat1 depends on transcriptional synergy with Sp1. J Biol Chem 270:30264-30267, 1995
126. Schaefer TS, Sanders LK, Nathans D: Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3. Proc Natl Acad Sci USA 92:9097-9101, 1995
127. Stocklin E, Wissler M, Gouilleux F, Groner B: Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383:726-728, 1996
128. Sperisen P, Wang SM, Soldaini E, Pla M, Rusterholz C, Bucher P, Corthesy P, Reichenbach P, Nabholz M: Mouse interleukin-2 receptor alpha gene expression. Interleukin-1 and interleukin-2 control transcription via distinct cis-acting elements. J Biol Chem 270:10743-10753, 1995
129. John S, Robbins CM, Leonard WJ: An IL-2 response element in the human IL-2 receptor alpha chain promoter is a composite element that binds Stat5, Elf-1, HMG-I(Y) and a GATA family protein. EMBO J 15:5627-5635, 1996
130. Lecine P, Algarte M, Rameil P, Beadling C, Bucher P, Nabholz M. Imbert J: Flf-1 and Stat5 bind to a critical element in a new enhancer of the human interleukin-2 receptor alpha gene. Mol Cell Biol 16:6829-6840, 1996
131. Li X, Leung S, Kerr IM, Stark GR: Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling. Mol Cell Biol 17:2048-2056, 1997
132. Haspel RL, Salditt-Georgieff M, Darnell JEJ: The rapid inactivation of nuclear tyrosine phosphorylated Stat1 depends upon a protein tyrosine phosphatase. EMBO J 15:6262-6268, 1996
133. Shuai K, Liao J, Song MM: Enhancement of antiproliferative activity of gamma interferon by the specific inhibition of tyrosine dephosphorylation of Stat1. Mol Cell Biol 16:4932-4941, 1996
134. Kim TK, Maniatis T: Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proleasome pathway. Science 273:1717-1719, 1996
135. Wang D, Stravopodis D, Teglund S, Kitazawa J, Ihle JN: Naturally occurring dominant negative variants of Stat5. Mol Cell Biol 16:6141-6148, 1996
136. Horvath CM, Darnell JEJ: The antiviral state induced by alpha interferon and gamma interferon requires transcriptionally active Stat1 protein. J Virol 70:647-650, 1996
137. Azam M, Lee C, Strehlow I, Schindler C: Functionally distinct isoforms of STAT5 are generated by protein processing. Immunity 6:691-701, 1997
138. Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM: Control of inflammation, cytokine expression and germinal center formation by BCL-6. Science 276:589-592, 1997
139. Ye BH, Cattoretti G, Shen Q, Zhang J, Hawe N, de Waard R, Leung C, Nouri-Shirazi M, Orazi A, Chaganti RS, Rothman P, Stall AM, Pandolfi PP, Dalla-Favera R: The BCL-6 protooncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 16:161-170, 1997
140. Chang MS, Chang GD, Leu JH, Huang FL, Chou CK, Huang CJ, Lo TB: Expression, characterization, and genomic structure of carp JAK1 kinase gene. DNA Cell Biol 15:827-844, 1996
141. Conway G, Margoliath A, Wong-Madden S, Roberts RJ, Gilbert W: Jak1 kinase is required for cell migrations and anterior specification in zebrafish embryos. Proc Natl Acad Sci USA 94:3082-3087, 1997
142. Binari R, Perrimon N: Stripe-specific regulation of pair-rule genes by hopscotch, a putative Jak family tyrosine kinase in Drosophila. Genes Dev 8:300-312, 1994
143. Luo H, Hanratty WP, Dearolf CR: An amino acid substitution in the Drosophila hopTum-1 Jak kinase causes leukemia-like hematopoietic defects. EMBO J 14:1412-1420, 1995
144. Hou XS, Perrimon N: The JAK-STAT pathway in Drosophila. Trends Genet 13:105-110, 1997
145. Hou XS, Melnick MB, Perrimon N: Marelle acts downstream of the Drosophila HOP/JAK kinase and encodes a protein similar to the mammalian STATs. Cell 84:411-419, 1996
146. Van R, Small S, Desplan C, Dearolf CR, Damell JEJ: Identification of a Stat gene that functions in Drosophila development. Cell 84:421-430, 1996
147. Van R, Luo H, Darnell JEJ, Dearolf CR: A JAK-STAT pathway regulates wing vein formation in Drosophila. Proc Natl Acad Sci USA 93:5842-5847, 1996
148. Kawata T, Shevchenko A, Fukuzawa M, Jermyn KA, Totty NF, Zhukovskaya NV, Sterling AE, Mann M. Williams JG: SH2 signaling in a lower eukaryote: A STAT protein that regulates stalk cell differentiation in Dietyostelium. Cell 89:909, 1997
149. Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBride OW, Leonard WJ: lnterleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73:147-157, 1993
150. Leonard WJ: The molecular basis of X-linked severe combined immunodeficiency: detective cytokine receptor signaling. Annu Rev Med 47:229-239, 1996
151. Russell SM, Keegan AD, Harada N, Nakamura Y, Noguchi M, Leland P, Friedmann MC, Miyajima A, Puri RK, Paul WE, et al.: Interleukin-2 receptor gamma chain: A functional component of the interleukin-4 receptor. Science 262:1880-1883, 1993
152. Noguchi M, Nakamura Y, Russell SM, Ziegler SF, Tsang M, Cao X, Leonard WJ: Interleukin-2 receptor gamma chain: A functional component of the interleukin-7 receptor. Science 262: 1877-1880, 1993
153. Kondo M, Takeshita T, Ishii N, Nakamura M, Watanabe S, Arai K, Sugamura K: Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science 262:1874-1877, 1993
154. Kondo M, Takeshita T, Higuchi M, Nakamura M, Sudo T, Nishikawa S, Sugamura K: Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. Science 263:1453-1454, 1994
155. Kimura Y, Takeshita T, Kondo M, Ishii N, Nakamura M, Van Snick J, Sugamura K: Sharing of the IL-2 receptor gamma chain with the functional IL-9 receptor complex. Int Immunol 7:115-120, 1995
156. Macchi P, Villa A, Gillani S, Sacco MG, Frattini A, Porta F, Ugazio AG, Johnston JA, Candotti F, O'Shea JJ, et al.: Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377:65-68, 1995
157. Buckley RH, Schiff RI, Schiff SE, Marken ML, Williams LW, Harville TO, Roberts JL, Puck JM: Human severe combined immunodeficiency: Genetic, phenotypic. and functional diversity in one hundred eight infants [see comments]. J Pediatr 130:378-387, 1997
158. Fischer A, Cavazzana-Calvo M, De Saint Basile G, De Vollartay JP, DiSanto JP, Hivroz C, Rieux-Laucat F, Le Deist F: Naturally occurring primary deficiencies of the immune system. Annu Rev Immunol 15:93-124, 1997
159. WHO Scientific Group: Primary immunodeficiency diseases: Report of a WHO scientific group. Clin Exp Immunol 99:1-24, 1995
160. Puck JM: IL2RGbase: A database of gamma c-chain defects causing human X-SCID. Immunol Today 17:507-511, 1996
161. Pepper AE, Buckley RH, Small TN, Puck JM: Two mutational hotspots in the interleukin-2 receptor gamma chain gene causing human X-linked severe combined immunodeficiency. Am J Hum Genet 57:564-571, 1995
162. Clark PA, Lester T, Genet S, Jones AM, Hendriks R, Levinsky RJ, Kinnon C: Screening for mutations causing X-linked severe combined immunodeficiency in the IL-2R gamma chain gene by single-strand conformation polymorphism analysis. Hum Genet 96:427-432, 1995
163. Morelon E, Dautry-Varsat A, Le Deist F, Hacein-Bay S, Fischer A, de Saint Basile G: T-lymphocyte differentiation and proliferation in the absence of the cytoplasmic tail of the common cytokine receptor gamma c chain in a severe combined immune deficiency X1 patient. Blood 88:1708-1717, 1996
164. Candotti F, Oakes SA, Giliani S, Johnston JA, Schumacher FR, Badolato R, Notarangelo LD, Bozzi F, Strina D, Vezzoni P, Blaese M, O'Shea JJ, Villa A: Structural and functional basis for JAK3-deficient severe combined immunodeficiency. Blood (in press)
165. DiSanto JP, Rieux-Laucat F, Dautry-Varsat A, Fischer A, de Saint Basile G: Defective human interleukin 2 receptor gamma chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells. Proc Natl Acad Sci USA 91:9466-9470, 1994
166. Puck JM, Nussbaum RL, Conley ME: Carrier detection in X-linked severe combined immunodeficiency based on patterns of X chromosome inactivation. J Clin Invest 79:1395-1400, 1987
167. Wengler GS, Allen RC, Parolini O, Smith H, Conley ME: Nonrandom X
168. Cao X, Shores EW, Hu-Li J, Anver MR, Kelsall BL, Russell SM, Drago J, Noguchi M, Grinberg A, Bloom ET. et al.: Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 2:223-238, 1995
169. DiSanto JP, Muller W, Guy-Grand D, Fischer A, Rajewsky K: Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci USA 92:377-381, 1995
170. Thomis DC, Gurniak CB, Tivol E, Sharpe AH, Berg LJ: Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 270:794-797, 1995
171. Nosaka T, van Deursen JM, Tripp RA, Thierfelder WE, Witthuhn BA, McMickle AP, Doherty PC, Grosveld GC, Ihle JN: Defective lymphoid development in mice lacking Jak3. Science 270:800-802, 1995
172. Park SY, Saijo K, Takahashi T, Osawa M, Arase H, Hirayama N, Miyake K, Nakauchi H, Shirusawa T, Sailo T: Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 3:771-782, 1995
173. Orlic D, Girard L, Lee D, Anderson S, Puck JM, Bodine D: Blood 86:10a, 1995
174. Candotti F, Johnston JA, Puck JM, Sugamura K, O'Shea JJ, Blaese RM: Retroviral-mediated gene correction for X-linked severe combined immunodeficiency. Blood 87:3097-3102, 1996
175. Taylor N, Uribe L, Smith S, Jahn T, Kohn DB, Weinberg K: Correction of interleukin-2 receptor function in X-SCID lymphoblastoid cells by retrovirally mediated transfer of the gamma-c gene. Blood 87:3103-3107, 1996
176. Taylor N, Candotti F, Smith S, Oakes SA, Jahn T, Isakov J, Puck JM, O'Shea JJ, Weinberg K, Johnston JA: Interleukin-4 signaling in B lymphocytes from patients with X-linked severe combined immunodeficiency. J Biol Chem 272:7314-7319, 1997
177. Matthews DJ, Clark PA, Herbert J, Morgan G, Armitage RJ, Kinnon C, Minty A, Grabstein KH, Caput D, Ferrara P, et al.: Function of the interleukin-2 (IL-2) receptor gamma-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-I5. Blood 85:38-42, 1995
178. Lai SY, Molden J, Liu KD, Puck JM, White MD, Goldsmith MA: Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor alpha subunit. EMBO J 15:4506-4514, 1996
179. Kammer W, Lischke A, Moriggl R, Groner B. Ziemiecki A, Gurniak CB, Berg LJ, Friedrich K: Homodimerization of interleukin-4 receptor alpha chain can induce intracellular signaling. J Biol Chem 271:23634-23637, 1996
180. Fujiwara H, Hanissian SH, Tsytsykova A, Geha RS: Homodimerization of the human interleukin 4 receptor alpha chain induces Cepsilon germline transcripts in B cells in the absence of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci USA 94:5866-5871, 1997
181. Nakajima H, Shores EW, Noguchi M, Leonard WJ: The common cytokine receptor gamma chain plays an essential role in regulating lymphoid homeostasis. J Exp Med 185:189-195, 1997
182. Saijo K, Park SY, Ishida Y, Arase H, Saito T: Crucial role of Jak3 in negative selection of self-reactive T cells. J Exp Med 185:351-356, 1997
183. Thomis DC, Berg LJ: Peripheral expression of Jak3 is required to maintain T lymphocyte function. J Exp Med 185:197-206, 1997
184. Beadling C, Guschin D, Witthuhn BA, Ziemiecki A, Ihle JN, Kerr IM, Cantrell DA: Activation of JAK kinases and STAT proteins by interleukin-2 and Interferon alpha, but not the T cell antigen receptor, in human T lymphocytes. EMBO J 13:5605-5615, 1994
185. Hanissian SH, Geha RS: Jak3 Is Associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity 6:379-387, 1997
186. Durhin JE, Hackenmiller R, Simon MC, Levy DE: Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84:443-450, 1996
187. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K. DuBois RN, Clark R, Aguet M, Schreiber RD: Targeted disruption of the Stall gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431-442, 1996
188. Kaplan MH, Sun YL, Hoey T, Grushy MJ: Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382:174-177, 1996
189. Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DA, Doherty PC, Grosveld GC, Ihlc JN: Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382:171 174, 1996
190. Kaplan MH, Schindler U, Smiley ST, Grushy MJ: Stat6 is required tor mediating responses to IL-4 and for development of Th2 cells. Immunity 4:313-319, 1996
191. Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, Chu C, Quelle FW, Nosaka T, Vignali DA, Doherty PC, Grosveld G, Paul WE, Ihle JN: Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630-633, 1996
192. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S: Essential role of Stat6 in IL-4 signaling. Nature 380:627-630, 1996
193. Takeda K, Kamanaka M, Tanaka T, Kishimoto T, Akira S: Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J Immunol 157:3220-3222, 1996
194. Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L: Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev 11:179-186. 1997
195. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park S-H, Ram PA, Waxman DJ. Davey HW: Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA 94:7239-7244, 1997
196. Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, Kishimoto T, Akira S: Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA 94:3801-3804, 1997
197. Hanratty WP, Dearolf CR: The Drosophila Tumorous-lethal hematopoietic oncogene is a dominant mutation in the hopscotch locus. Mol Gen Genet 238:33-37, 1993
198. Harrison HA, Binari R, Nahreini TS, Gilman M, Perrimon N: Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects. EMBO J 14:2857-2865, 1995
199. Luo H, Rose P, Barber D, Hanratty WP, Lee S, Roberts TM, DAndrea AD, Dearolf CR: Mutation in the JAK kinase JH2 domain hyperactivates Drosophila and mammalian JAK-STAT pathways. Mol Cell Biol 17:1562-1571, 1997
200. Migone TS, Lin JX, Cereseto A, Mulloy JC, O'Shea JJ. Franchini G, Leonard WJ: Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-L Science 269:79-81, 1995
201. Zhang Q, Nowak I, Vonderheid EC, Rook AH, Kadin ME. Nowell PC, Shaw LM, Wasik MA: Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc Natl Acad Sci USA 93:9148-9153, 1996
202. Danial NN, Pernis A, Rothman PB: Jak-STAT signaling induced by the v-abl oncogene. Science 269:1875-1877, 1995
203. Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M, Cohen A, Gazit A, Levitzki A, Roifman CM: Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 379:645-648, 1996
204. Cao X, Tay A, Guy GR, Tan YH: Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol Cell Biol 16:1595-1603, 1996
205. Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J, Jove R: Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269:81-83, 1995
206. Hilbert DM, Migone TS, Kopf M, Leonard WJ, Rudikoff S: Distinct tumorigenic potential of abl and raf in B cell neoplasia: abl activates the IL-6 signaling pathway. Immunity 5:81-89, 1996
207. Ohashi T, Masuda M, Ruscetti SK: Induction of sequence-specific DNA-binding factors by erythropoietin and the spleen focus-forming virus. Blood 85:1454-1462, 1995
208. Carlesso N, Frank DA, Griffin JD: Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J Exp Med 183:811-820, 1996
209. Ilaria RLJ, Van Etten RA: P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J Biol Chem 271:31704-31710, 1996
210. Shuai K, Halpern J, ten Hoeve J, Rao X, Sawyers CL: Constitutive activation of STATS by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 13:247-254, 1996
211. Gouilleux-Gruart V, Gouilleux F, Desaint C, Claisse JF, Capiod JC, Delohel J, Weber-Nordt R, Dusanter-Fourt I, Dreyfus F, Groner B, Prin L: STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood 87:1692-1697, 1996
212. Weber-Nordt RM, Egen C, Wehinger J, Ludwig W, Gouilleux-Gruart V, Mertelsmann R, Finke J: Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 88:809-816, 1996
213. Kanwar VS, Witthuhn B, Campana D, Ihle JN: Lack of constitutive activation of Janus kinases and signal transduction and activation of transcription factors in Philadelphia chromosome-positive acute lymphoblastic leukemia [letter]. Blood 87:4911-4912, 1996
214. Schmalstieg FC, Leonard WJ, Noguchi M, Berg M, Rudloff HE, Denney RM: Missense mutation in exon 7 of the common gamma chain gene causes a moderate form of X-linked combined immunodeficiency. J Clin Invest 95:1169-1173, 1995
215. Hacein-Bey H, Cavazzana-Calvo M, Le Deist F, Dautry-Varsat A, Hivroz C. Riviere I, Danos O, Heard JM, Sugamura K, Fischer A, De Saint Basile G: Gamma-c gene transfer into SCID X1 patients' B-cell lines restores normal high-affinity interleukin-2 receptor expression and function. Blood 87:3108-3116, 1996